Self-management of oral anticoagulation;Übersichtsarbeit:Selbstmanagement der oralen antikoagulation

Deutsches Arzteblatt International

Volumn 111, Issue 6, 2014, Pages

  Siebenhofer, Andrea ^a,b   Jeitler, Klaus ^b   Horvath, Karl ^b,c   Habacher, Wolfgang ^d   Schmidt, Louise ^d   Semlitsch, Thomas ^b  

^a GOETHE UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c Klinische Abteilung für Endokrinologie und Stoffwechsel   (Germany)

^d HEALTH Institut für Biomedizin und Gesundheitswissenschaften   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULATION; CARDIOVASCULAR MORTALITY; HUMAN; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELF CARE; SELF EXAMINATION; SYSTEMATIC REVIEW; THROMBOEMBOLISM; BLOOD CLOTTING TEST; DRUG SELF ADMINISTRATION; MEDICATION COMPLIANCE; META ANALYSIS; ORAL DRUG ADMINISTRATION; PREVALENCE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ANTICOAGULANT AGENT;

ADMINISTRATION, ORAL; ANTICOAGULANTS; BLOOD COAGULATION TESTS; HUMANS; MEDICATION ADHERENCE; PREVALENCE; SELF ADMINISTRATION; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84903371990     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2014.0083     Document Type: Review

References (52)

1. Hirsh J: Oral anticoagulant drugs. N Engl J Med 1991; 324: 1865-75.
2. Hein L: Antithrombotika und Antihämorrhagika. In: Schwabe U, Paffrath D, (eds.): Arzneiverordnungs-Report 2011: Berlin, Heidelberg. Springer 2011; 421-39.
3. Sawicki PT: A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 1999; 281: 145-50. (Pubitemid 29045346)
4. Voller H, Dovifat C, Glatz J, Kortke H, Taborski U, Wegscheider K: Self management of oral anticoagulation with the IN Ratio system: impact of a structured teaching program on patient's knowledge of medical background and procedures. Eur J Cardiovasc Prev Rehabil 2004; 11: 442-7. (Pubitemid 39491067)
5. Watzke H: Patienten-Compliance beim Gerinnungs-Selbstmanagement. Die Punkte - DFP Literatur 2011; Angiologie 2/2011:8.
6. Siebenhofer A, Hemkens LG, Rakovac I, Spat S, Didjurgeit U: Selfmanagement of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thromb Res 2012; 130: e60-6.
7. Heneghan C, Ward A, Perera R, et al.: Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. [Review] [Erratum appears in Lancet 2012; 379: 1102]. Lancet 2012; 379: 322-34.
8. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG): Allgemeine Methoden: Version 4.0. 2011. www.iqwig.de/download/IQWiG-Methoden-Version-4-0.pdf. Last accessed on 13 March 2013.
9. Higgins J, Green S: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 2011. The Cochrane Collaboration. www.cochrane-handbook.org. Last accessed on 13. March 2013.
10. Oxman AD, Guyatt GH: Validation of an index of the quality of review articles. J Clin Epidemiol 1991; 44: 1271-8.
11. Oxman AD, Guyatt GH, Singer J, et al.: Agreement among reviewers of review articles. J Clin Epidemiol 1991; 44: 91-8.
12. Siebenhofer-Kroitzsch A, Semlitsch T: Selbstmanagement der oralen Antikoagulation - Evidenz und Ist-Analyse in Österreich 2013. Hauptverband der österreichischen Sozialversicherungsträger. www.hauptverband.at/ mediaDB/953046-Bericht-Selbstmanage ment-orale-Antikoagulation.pdf. Last accessed on 13. March 2013.
13. Bloomfield HE, Krause A, Greer N, et al.: Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Annals of Internal Medicine 2011; 154: 472-82.
14. Garcia-Alamino JM, Ward AM, Alonso-Coello P, et al.: Selfmonitoring and self-management of oral anticoagulation. [Review] [83 refs]. Cochrane Database of Systematic Reviews 2010(4): CD003839.
15. Xu Z, Wang Z, Ou J, Xu Y, Yang S, Zhang X: Two monitoring methods of oral anticoagulant therapy in patients with mechanical heart valve prothesis: a meta-analysis. Journal of Thrombosis & Thrombolysis 2012; 33: 38-47.
16. Christensen TD, Johnsen SP, Hjortdal VE, Hasenkam JM: Selfmanagement of oral anticoagulant therapy: a systematic review and meta-analysis. International Journal of Cardiology 2007; 118: 54-61. (Pubitemid 46517685)
17. Connock M, Stevens C, Fry-Smith A, et al.: Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assess. 2007; 11(38): iii-iv, ix-66.
18. Health Quality O: Point-of-care international normalized ratio (INR) monitoring devices for patients onlong-term oral anticoagulation therapy: An evidence-based analysis. Ontario Health Technology Assessment Series 2009; 9: 1-114.
19. Wells PS, Brown A, Jaffey J, McGahan L, Poon MC, Cimon K: Safety and effectiveness of point-of-care monitoring devices in patients on oral anticoagulant therapy: a meta-analysis. Open Med 2007; 1: e131-46. Epub 2007 Oct 16.
20. Siebenhofer A, Rakovac I, Kleespies C, Piso B, Didjurgeit U: Selfmanagement of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thromb Haemost 2008; 100: 1089-98.
21. Granger CB, Alexander JH, McMurray JJ, et al.: Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-92.
22. Patel MR, Mahaffey KW, Garg J, et al.: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-91.
23. Wallentin L, Yusuf S, Ezekowitz MD, et al.: Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 2010; 376: 975-83.
24. Saal K, Hofmann B, Blauth E, et al.: Identifying safety problems in the General Practice - analysis of the treatment process of oral anticoagulation therapy. Zeitschrift für Allgemeinmedizin 2009; 85: 148-55.
25. Eikelboom JW, Connolly SJ, Brueckmann M, et al.: Dabigatran versus Warfarin in patients with mechanical heart valves. N Engl J Med 2013.
26. Neue Indikationen für Faktor Xa-Hemmstoff Rivaroxaban (Xarelto). Arznei-Telegramm 2012; 43: 2-12.
27. Schwabe U, Paffrath D (eds.): Arzneiverordnungs-Report 2013 - Aktuelle Daten, Kosten, Trends und Kommentare. Berlin: Springer- Verlag GmbH 2013.
28. Arzneimittelkommission der deutschen Ärztschaft (AkdÄ): Orale Antikoagulation bei nicht valvulären Vorhofflimmern - Empfehlungen zum Einsatz der neuen Antikoagulantien Dabigatran (Pradaxa) und Rivaroxaban (Xarelto). 2012. www.akdae.de/Arzneimittel therapie/TE/LF/PDF/OAKVHF.pdf. Last accessed on 8. November 2012.
29. Siebenhofer A, Ulrich LR, Mergenthal K, et al.: Primary care management for optimized antithrombotic treatment [PICANT]: study protocol for a cluster-randomized controlled trial. Implement Sci 2012; 7: 79.
30. White RH, McCurdy SA, von Marensdorff H, et al.: Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine 1989; 111: 730-7. (Pubitemid 19266112)
31. e2. Horstkotte D, Piper C, Wiemer M: Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease. Journal of Thrombosis and Thrombolysis 1998; 5 (Suppl 1): 19-24.
32. e3. Beyth RJ, Quinn L, Landefeld CS: A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine 2000; 133: 687-95.
33. e4. Cromheecke ME, Levi M, Colly LP, et al.: Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000; 356: 97-102. (Pubitemid 30438510)
34. e5. Kaatz S, Elston-Lafata J, Gooldy S: Anticoagulation therapy home and office monitoring evaluation study. J Thromb Thrombolysis 2001; 12: 111.
35. e6. Kortke H, Minami K, Breymann T, et al.: [INR self-management after mechanical heart valve replacement: ESCAT (Early Self- Controlled Anticoagulation Trial)]. Zeitschrift fur Kardiologie 2001; 90 (Suppl 6): 118-24 (Pubitemid 34048827)
36. Sidhu P, O'Kane HO: Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. The Annals of Thoracic Surgery 2001; 72: 1523-7. (Pubitemid 33049754)
37. e8. Fitzmaurice DA, Murray ET, Gee KM, et al.: A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology 2002; 55: 845-9. (Pubitemid 35316252)
38. e9. Gadisseur AP, Breukink-Engbers WG, van der Meer FJ, et al.: Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine 2003; 163: 2639-46. (Pubitemid 37464423)
39. e10. Khan TI, Kamali F, Kesteven P, et al. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology 2004; 126 (4): 557-64. (Pubitemid 39093099)
40. e11. Sunderji R, Gin K, Shalansky K, et al.: A randomized trial of patient self-managed versus physician-managed oral anticoagulation. The Canadian Journal of Cardiology 2004; 20: 1117-23. (Pubitemid 39302738)
41. e12. Claes N, Buntinx F, Vijgen J, et al. The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial. European Heart Journal 2005; 26: 2159-65. (Pubitemid 41408000)
42. e13. Fitzmaurice DA, Murray ET, McCahon D, et al. Self management of oral anticoagulation: randomised trial. BMJ (Clinical re - searched). 2005; 331: 1057.
43. e14. Gardiner C, Williams K, Mackie IJ, et al.: Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology 2005; 128: 242-7.
44. e15. Menendez-Jandula B, Souto JC, Oliver A, et al. Comparing selfmanagement of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine 2005; 142: 1-10.
45. e16. Voller H, Glatz J, Taborski U, et al. Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie 2005; 94: 182-6. (Pubitemid 40394900)
46. e17. Christensen TD, Maegaard M, Sorensen HT, et al.: Selfmanagement versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine 2006; 17: 260-6. (Pubitemid 43817515)
47. e18. Gardiner C, Williams K, Longair I, et al.: A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. British Journal of Haematology 2006; 132: 598-603. (Pubitemid 43381593)
48. e19. Dauphin C, Legault B, Jaffeux P, et al.: Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases 2008; 101: 753-61.
49. e20. Eitz T, Schenk S, Fritzsche D, et al.: International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. The Annals of Thoracic Surgery. 2008; 85: 949-54; discussion 55.
50. e21. Ryan F, Byrne S, O'Shea S: Randomized controlled trial of super vised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis 2009; 7: 1284-90.
51. e22. Soliman Hamad MA, van Eekelen E, van Agt T, et al.: Selfmanagement program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardio-Thoracic Surgery. 2009; 35: 265-9.
52. e23. Matchar DB, Jacobson A, Dolor R, et al. Effect of home testing of international normalized ratio on clinical events. NEJM 2010; 363: 1608-20.